JPY 798.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 124 Million JPY | 571.05% |
2022 | 697.06 Million JPY | -96.0% |
2021 | 500.79 Million JPY | 6.03% |
2020 | 292.21 Million JPY | 1505.91% |
2019 | -44.6 Million JPY | -108.84% |
2018 | 282.07 Million JPY | -42.24% |
2017 | 608.54 Million JPY | -2.83% |
2016 | 634.89 Million JPY | -20.77% |
2015 | 671.79 Million JPY | -24.19% |
2014 | 1.17 Billion JPY | -4.79% |
2013 | 1.08 Billion JPY | 2.73% |
2012 | 1.06 Billion JPY | 2.36% |
2011 | 994.66 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 39.83 Million JPY | 222.42% |
2024 Q2 | 53.38 Million JPY | -14.26% |
2023 FY | - JPY | 571.05% |
2023 Q3 | 189.11 Million JPY | 373.16% |
2023 Q1 | -2.95 Million JPY | 95.74% |
2023 Q4 | -50.86 Million JPY | -126.9% |
2023 Q2 | -69.23 Million JPY | -2241.36% |
2022 Q4 | -69.48 Million JPY | -133.31% |
2022 FY | - JPY | -96.0% |
2022 Q3 | 208.6 Million JPY | 2185.11% |
2022 Q2 | 9.12 Million JPY | 103.83% |
2022 Q1 | -238.62 Million JPY | -193.77% |
2021 Q1 | 126.78 Million JPY | 130.28% |
2021 FY | - JPY | 6.03% |
2021 Q3 | 164.92 Million JPY | 16.84% |
2021 Q4 | -81.22 Million JPY | -149.25% |
2021 Q2 | 141.15 Million JPY | 11.33% |
2020 Q1 | -6.87 Million JPY | 92.82% |
2020 Q3 | 263.01 Million JPY | 1786.74% |
2020 FY | - JPY | 1505.91% |
2020 Q2 | 13.94 Million JPY | 302.7% |
2020 Q4 | 55.05 Million JPY | -79.07% |
2019 Q4 | -95.72 Million JPY | -157.68% |
2019 FY | - JPY | -108.84% |
2019 Q1 | -164.92 Million JPY | -103.14% |
2019 Q2 | -53.89 Million JPY | 67.32% |
2019 Q3 | 165.96 Million JPY | 407.91% |
2018 FY | - JPY | -42.24% |
2018 Q3 | 154.01 Million JPY | 30.42% |
2018 Q2 | 118.08 Million JPY | 94.32% |
2018 Q1 | 60.77 Million JPY | 204.28% |
2018 Q4 | -81.18 Million JPY | -152.71% |
2017 Q4 | -58.27 Million JPY | -125.79% |
2017 Q2 | 143.32 Million JPY | -27.84% |
2017 Q1 | 198.6 Million JPY | 293.88% |
2017 Q3 | 225.94 Million JPY | 57.65% |
2017 FY | - JPY | -2.83% |
2016 FY | - JPY | -20.77% |
2016 Q2 | 112.3 Million JPY | -31.53% |
2016 Q4 | -102.43 Million JPY | -128.83% |
2016 Q3 | 355.3 Million JPY | 216.37% |
2016 Q1 | 164.01 Million JPY | 1185.85% |
2015 FY | - JPY | -24.19% |
2015 Q4 | -15.1 Million JPY | -105.09% |
2015 Q3 | 296.94 Million JPY | 69.89% |
2015 Q2 | 174.78 Million JPY | -31.17% |
2015 Q1 | 253.92 Million JPY | -2.68% |
2014 Q2 | 143.03 Million JPY | -28.66% |
2014 Q1 | 200.49 Million JPY | 959.8% |
2014 FY | - JPY | -4.79% |
2014 Q4 | 260.9 Million JPY | -25.62% |
2014 Q3 | 350.76 Million JPY | 145.23% |
2013 FY | - JPY | 2.73% |
2013 Q3 | 448.83 Million JPY | 82.16% |
2013 Q4 | 18.91 Million JPY | -95.79% |
2013 Q1 | 296.02 Million JPY | 483.56% |
2013 Q2 | 246.39 Million JPY | -16.77% |
2012 Q4 | 50.72 Million JPY | -86.36% |
2012 Q3 | 371.85 Million JPY | 0.0% |
2012 FY | - JPY | 2.36% |
2011 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | 92.191% |
Euglena Co., Ltd. | 676 Million JPY | 81.657% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | 93.689% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | 77.688% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 96.91% |
Kao Corporation | 154.49 Billion JPY | 99.92% |
Niitaka Co., Ltd. | 1.36 Billion JPY | 90.946% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 99.746% |
Shiseido Company, Limited | 106.46 Billion JPY | 99.884% |
Lion Corporation | 42.31 Billion JPY | 99.707% |
Mandom Corporation | 6.69 Billion JPY | 98.149% |
Ivy Cosmetics Corporation | 242.6 Million JPY | 48.887% |
Milbon Co., Ltd. | 7.8 Billion JPY | 98.41% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | 90.377% |
Fancl Corporation | 16.6 Billion JPY | 99.253% |
KOSÉ Corporation | 26.85 Billion JPY | 99.538% |
Cota Co., Ltd. | 2.26 Billion JPY | 94.534% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 109.435% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | 27.843% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 99.465% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 98.987% |
Almado, Inc. | 983.21 Million JPY | 87.388% |
I-ne CO., LTD. | 4.7 Billion JPY | 97.362% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 119.777% |
Liberta Co.,Ltd. | 318.19 Million JPY | 61.03% |
AXXZIA Inc. | 1.28 Billion JPY | 90.362% |
S.T. Corporation | 2.62 Billion JPY | 95.278% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 99.609% |
Earth Corporation | 10.6 Billion JPY | 98.831% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | 88.671% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 121.604% |
Ya-Man Ltd. | 1.43 Billion JPY | 91.37% |
MTG Co., Ltd. | 4.39 Billion JPY | 97.178% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 97.865% |
SHOBIDO Corporation | 1.11 Billion JPY | 88.831% |
Artnature Inc. | 3.78 Billion JPY | 96.726% |
Pigeon Corporation | 15.8 Billion JPY | 99.215% |
Unicharm Corporation | 178.01 Billion JPY | 99.93% |
Paltac Corporation | 35.92 Billion JPY | 99.655% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 96.225% |